These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 6755025

  • 21. Hepatitis B surface antigen in hepatocytes at necropsy.
    Ho JC, Wu PC, Gibson JB.
    Arch Pathol Lab Med; 1980 May; 104(5):255-7. PubMed ID: 6245627
    [Abstract] [Full Text] [Related]

  • 22. Changes in liver histology as a "surrogate" end point of antiviral therapy for chronic HBV can predict progression to liver complications.
    Hui CK, Leung N, Shek WH, Zhang HY, Luk JM, Poon RT, Lo CM, Fan ST, Lau GK, Hong Kong Liver Fibrosis Study Group.
    J Clin Gastroenterol; 2008 May; 42(5):533-8. PubMed ID: 18344885
    [Abstract] [Full Text] [Related]

  • 23. Long-term effect of interferon therapy on incidence of cirrhosis and hepatocellular carcinoma in Thai patients with chronic hepatitis B.
    Tangkijvanich P, Thong-ngam D, Mahachai V, Kladchareon N, Suwangool P, Kullavanijaya P.
    Southeast Asian J Trop Med Public Health; 2001 Sep; 32(3):452-8. PubMed ID: 11944697
    [Abstract] [Full Text] [Related]

  • 24. Resistance to iron accumulation and presence of hepatitis B surface antigen in preneoplastic and neoplastic lesions in human hemochromatotic livers.
    Hirota N, Hamazaki M, Williams GM.
    Hepatogastroenterology; 1982 Apr; 29(2):49-51. PubMed ID: 6282722
    [Abstract] [Full Text] [Related]

  • 25. Cancer incidence in atomic bomb survivors. Part IV: Comparison of cancer incidence and mortality.
    Ron E, Preston DL, Mabuchi K, Thompson DE, Soda M.
    Radiat Res; 1994 Feb; 137(2 Suppl):S98-112. PubMed ID: 8127954
    [Abstract] [Full Text] [Related]

  • 26. Epidemiology of hepatocellular carcinoma. Evaluation of viral and other risk factors in a low-endemic area for hepatitis B and C.
    Peters M, Wellek S, Dienes HP, Junginger T, Meyer J, Meyer Zum Büschendfelde KH, Gerken G.
    Z Gastroenterol; 1994 Mar; 32(3):146-51. PubMed ID: 8197809
    [Abstract] [Full Text] [Related]

  • 27. Long-term trend of decreasing frequency of hepatitis B virus infection.
    Senba M, Nakamura T, Senba MI, Watanabe M, Zhong X, Itakura H.
    Acta Virol; 1993 Mar; 37(2-3):199-201. PubMed ID: 8105668
    [Abstract] [Full Text] [Related]

  • 28. The risk and predictive factors for developing liver cancer among patients with decompensated liver cirrhosis.
    Kato I, Tominaga S, Ikari A.
    Jpn J Clin Oncol; 1992 Aug; 22(4):278-85. PubMed ID: 1279245
    [Abstract] [Full Text] [Related]

  • 29. Risk factors for hepatocellular carcinoma in patients with liver cirrhosis.
    Macías Rodríguez MA, Rendón Unceta P, Tejada Cabrera M, Infante Hernández JM, Correro Aguilar F, Díaz García F, Benítez Rodríguez E, Mangas Rojas A, Martín Herrera L.
    Rev Esp Enferm Dig; 2000 Jul; 92(7):458-69. PubMed ID: 11026763
    [Abstract] [Full Text] [Related]

  • 30. Multiple myeloma among atomic bomb survivors in Hiroshima and Nagasaki, 1950-76: relationship to radiation dose absorbed by marrow.
    Ichimaru M, Ishimaru T, Mikami M, Matsunaga M.
    J Natl Cancer Inst; 1982 Aug; 69(2):323-8. PubMed ID: 6955540
    [Abstract] [Full Text] [Related]

  • 31. [Study on the natural history of chronic hepatitis B].
    Wu G, Zhou W, Zhao Y, Guo S, Wang Z, Zou S, Zhang Q, Ren H, Huang A, Zhang D.
    Zhonghua Gan Zang Bing Za Zhi; 2002 Feb; 10(1):46-8. PubMed ID: 11856503
    [Abstract] [Full Text] [Related]

  • 32. Effects of radiation on the longitudinal trends of total serum cholesterol levels in the atomic bomb survivors.
    Wong FL, Yamada M, Sasaki H, Kodama K, Hosoda Y.
    Radiat Res; 1999 Jun; 151(6):736-46. PubMed ID: 10360794
    [Abstract] [Full Text] [Related]

  • 33. Hepatitis associated antigen and antibody in A-bomb survivors and nonexposed subjects in Hiroshima and Nagasaki.
    Belsky JL, Okochi K, Ishimaru T, Hamilton HB.
    Radiat Res; 1972 Dec; 52(3):528-35. PubMed ID: 4539561
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Analysis of risk factors for hepatocellular carcinoma that is negative for hepatitis B surface antigen (HBsAg).
    Shimada S, Aizawa R, Abe H, Suto S, Miyakawa Y, Aizawa Y.
    Intern Med; 2003 May; 42(5):389-93. PubMed ID: 12793707
    [Abstract] [Full Text] [Related]

  • 36. Prevalence of hepatitis B surface antigen among patients suspected of liver diseases in a Nigerian hospital.
    Baba MM, Ajayi BB, Ekanem IA.
    Niger Postgrad Med J; 2000 Sep; 7(3):91-5. PubMed ID: 11257921
    [Abstract] [Full Text] [Related]

  • 37. Aflatoxin, viral hepatitis and primary liver cancer.
    Stora C, Dvorackova I.
    J Med; 1987 Sep; 18(1):23-41. PubMed ID: 3036991
    [Abstract] [Full Text] [Related]

  • 38. A clinicpathological study of hepatocellular carcinoma in Nagasaki, south-western Japan: the association of hepatitis B and C viruses.
    Eto H, Toriyama K, Itakura H.
    Southeast Asian J Trop Med Public Health; 1994 Mar; 25(1):88-92. PubMed ID: 7529945
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.